2 High-Flying Vaccine Stocks with More Upside Potential By StockNews

© Reuters. 2 High-Flying Vaccine Stocks with More Upside Potential

With the advent of the COVID-19 omicron variant, vaccine developers are again the recipients of heightened investor attention. The success of Pfizer’s (PFE) and BioNTech’s (BNTX) COVID-19 vaccines has helped these stocks soar in price over the past few months, and they could continue gaining. So, we think it could be wise to add them to one’s portfolio now. Read on.Discovered only a few weeks ago, the COVID-19 omicron variant is now the dominant strain in the United States, accounting for roughly 73% of cases. The Biden administration has been taking steps to contain its spread. Last month, the White House’s COVID-19 response coordinator, Jeff Zients, said, “We’re working with Pfizer , Moderna (NASDAQ:), and (Johnson & Johnson) to develop contingency plans for modifications to vaccines or boosters if they’re needed.”

With the rapid spread of the new variant across several parts of the world, the demand for COVID-19 vaccines and booster shots is expected to increase significantly. According to a BCC Research report, the global market for vaccine technologies is expected to grow at a 7.6% CAGR over the next five years to $55.10 billion.

Therefore, we think it could be wise to bet on quality COVID-19 vaccine stocks Pfizer Inc. (NYSE:) and BioNTech SE (NASDAQ:). They have gained significantly in price, especially with the emergence of the omicron variant. And these stocks are expected to continue rallying in the coming months.

Continue reading on StockNews

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*